If you think anyone believes you have $1.2 million to invest with, I have some under water property I can sell you! Cheap! Really Cheap!!! LOl... Where do these morons come from????
Baird analyst Brian Skorney reiterated an Outperform rating and $258 price target on Intercept Pharmaceuticals (NASDAQ: ICPT) saying an FDA authored hepatology articles provides a window into Phase 3 design.
"We're further encouraged on Intercept after the workshop manuscript from the joint meeting with the AASLD and FDA regarding endpoints in NASH trials was published in Hepatology," Skorney said. "We believe that the FDA is essentially acknowledging a path for approval in the article based on a surrogate that aligns well with the endpoint Intercept plans to target in a Phase 3 study."
For an analyst ratings summary and ratings history on Intercept Pharmaceuticals click here. For more ratings news on Intercept Pharmaceuticals click here.
Roth Capital affirms Canadian Solar (Nasdaq: CSIQ) at Buy with a price target of $40 following Q3 results and guidance.
Analyst Philip Shen offered some overall thoughts on the company following results: “Despite a strong Q3 performance, weaker-than-expected margin guidance spooked investors. The market psychology for solar stocks has been challenging of late with any type of weakness serving as the lightning rod of attention. Given its capacity expansion plans, best-in-class brand, strong B/S, and rich downstream set of projects, we continue to believe that CSIQ is one of the best companies among its peers.”
Key takeaways from the report:
1. ASPs. Q4 ASPs could be as low as 63-64c/W due to mix and currency movements;
2. Q4 GMs may experience a few headwinds. Duty deposits could result in a 2% reduction in GMs; ASPs could decline due to geographic mix; Currency weakness may result in a 1-2% negative impact; Project sales may not be as margin rich as Q3; and
3. Quality balance sheet continues to improve due to strong contribution from core module business as well as high margin project sales. Cash in the Q4 increased from $341mn in Q2 to $408mn which helped to improve the net debt/cap ratio which declined from 47.7% in Q2 36.1% in Q3. We believe, over the next year, CSIQ's balance sheet could continue to strengthen as we estimate ~$240mn of cash could be raised from the sale of the 387MW Canadian project backlog
Greetings from the Seeking Alpha moderation team. It turns out users often disagree regarding the investment ideas presented on the site. It has also become clear that these disagreements can spark grand debates that help readers make informed decisions. This only works however, when users keep the conversation centered on the investment thesis and do not resort to personal attacks or blanket dismissals of other users’ ideas. The comment copied below looks to contain such a personal attack and/or blanket dismissal and so, regrettably, we’re compelled to remove it.
Please understand that we do strive to err on the side of facilitating free and open debate. This means that we are never happy about having to remove a comment. That said, in order to ensure that Seeking Alpha continues to be the go-to destination for serious investment discussion, comments must adhere to our guidelines, which can be found here: http://seekingalpha.com/page/comment_guidelines?source=moddeletion
Right on queue Matt as soon as you HLF will go up in price, you & your band of thieves post a hit piece on HLF. Priceless!!! More like worthless. Matt you are spineless....
U.S. confirms duties on solar goods from China, Taiwan
Tue Dec 16, 2014 11:31pm GMT
WASHINGTON Dec 16 (Reuters) - The United States confirmed steep import duties on solar products from China and Taiwan on Tuesday, according to a statement from the Department of Commerce.
Anti-dumping duties for Chinese goods were set as high was 165.04 percent as the U.S. arm of German solar manufacturer SolarWorld AG seeks to close a loophole which allowed Chinese producers to sidestep duties imposed in 2012.
Taiwanese producers face anti-dumping duties as high as 27.55 percent, according to the final Commerce decision. Producers in China also face separate anti-subsidy duties.
The duties, which will affect companies including China's Trina Solar Ltd and Suntech Power and Taiwan's Motech Industries Inc, must still be confirmed by the U.S. International Trade Commission.
Genworth Financial (NYSE: GNW) is getting slammed 36% early Thursday following the company's earnings miss and more importantly as an LTC review has extended to its Active Life Reserves (ALR).
As noted earlier, Compass Point analyst Ken Billingsley downgraded the shares and suspended its price target and estimates as a result, saying this will negatively impact investor sentiment until the reserve review is completed following the end of 4Q14.
"We had originally estimated the potential for a 15% reserve charge against the company’s DLR would not require the company to raise capital," Billingsley said. "However, we believe the market will anticipate a capital raise following the company’s further review of the larger Active Life Reserves."
He added, "While management expects to offset the impact from this ALR review through various “related management actions”, it will not be able to offset the impact to older blocks of business that were acquired. While we don’t believe the impact to ALR and TBVPS will be as severe as our initial assumptions on the following page, we illustrate what we believe the market will likely initially assume.. Depending on various factors, we believe the m
With $10 Billion in debt, very small amount of cash on hand, & with cash flow barley able to meet debt loads, its a miracle it's still trading above $7
CFO just said no buy back. They have to come up with $800 million by 2016 to pay off huge debt. Dead money for at least the next 2 qts
Northland Capital Markets analyst Colin Rusch raised estimates and his price target on Outperform-rated Canadian Solar (NASDAQ: CSIQ) to $48.00 (from $47.00) following Q3 results.
The analyst said fears of peak earnings are unfounded.
Q4 EPS goes from $1.38 to $1.39, FY 2014 EPS goes from $3.71 to $4.20 and FY 2015 EPS goes from $4.66 to $4.83.
No such thing as climate change. The only climate change taking place is between your liberals ears. What as mindless fool to believe in such crab.
The DOC's preliminary findings determined that producers and exporters in China will be subject to a countervailing subsidy rate ranging from 18.56% to 35.21%. According to the findings, JinkoSolar will be subject to a preliminary subsidy rate of 26.89%; at the mid-point of the range.
"We are disappointed to see the DOC's preliminary decision and believe that this will have a negative impact on the solar industry and will ultimately end up hurting US customers and US solar jobs the most," commented Mr. Xiande Li, Chairman of JinkoSolar. "Ill-conceived trade barriers such as these only aid in reducing the competitiveness of solar energy against other forms of power generation. JinkoSolar has fully cooperated with the relevant authorities throughout the investigation and will continue to do so in the hope that international trade and fair competition will eventually prevail. While we respect the DOC's decision, we strongly disagree with it. With a balanced and geographically diverse customer base, the tariffs are unlikely to have a significant impact on our entire business. We will continue to actively serve our customers in the US while we seek out other growth opportunities."
Hay moron, why don't u dispute what he post instead of calling him names? Because u can't. Congregations,your the mew MB idiot.
15 Analyst have sell or underperform 14 hold ( code word sell) & 2 buys
So why in the hell would you buy this stock? Let me guess Uncle Carl said buy, so u fools bought LOl.... Option players are beating big that by Jan Rig trades under $15. Keep buying those dips boys!
$27 by the end of the day.
Iberia Capital upgraded Baker Hughes (NYSE: BHI) from Sector Perform to Outperform with a price target of $65.00.
Someone just sold 3500 March $30 puts for $5.90 & bought 3500 March 35 calls for $4.50 Some one believes this is going back up